Jantunen, E., Relander, T., Lauritzsen, G., Hagberg, H., Anderson, H., Cavallin-Ståhl, E., Holte, H., Østerborg, A., Merup, M., Brown, P., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Østenstad, B., Sundström, C., Delabie, J., Ralfkier, E., Vornanen, M.
& D'Amore, F. A. (2011).
Intensive induction chemotherapy followed by autologous stem cell transplantation (ASCT) in patients with enteropathy-associated T-cell lymphoma: a prospective study by the Nordic Lymphoma Group (NLG-T-01).
Blood,
116(21), 3565.
Hybel, T. E., Vase, M. Ø., Maksten, E. F.
, Enemark, M. B., Lauridsen, K. L., Hamilton-Dutoit, S., Andersen, C., Møller, M. B., Sørensen, S. S.
, Jespersen, B., Kampmann, J.
, d'Amore, F. & Ludvigsen, M. (2021).
Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorder.
Acta Oncologica,
60(12), 1637-1642.
https://doi.org/10.1080/0284186X.2021.1973093
Hybel, T. E., Vase, M. Ø.
, Lauridsen, K. L., Enemark, M. B., Møller, M. B., Pedersen, C., Pedersen, G.
, Hamilton-Dutoit, S., Obel, N.
, Schade Larsen, C., d’Amore, F. & Ludvigsen, M. (2022).
CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus.
Leukemia and Lymphoma,
63(6), 1479-1483.
https://doi.org/10.1080/10428194.2021.2023741
Hutchings, M., Loft, A., Hansen, M., Pedersen, L. M., Berthelsen, A. K.
, Keiding, S., d'Amore, F. A., Boesen, A. M., Mikkelsen, L. R. & Specht, L. (2006).
Positron emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
Haematologica,
91, 482-9.
Hussmann, D.
, Starnawska, A., Kristensen, L.
, Daugaard, I., Thomsen, A.
, Kjeldsen, T., Hansen, C. S., Bybjerg-Grauholm, J., Dalsgaard Johansen, K.
, Ludvigsen, M., Kristensen, T., Larsen, T. S., Møller, M. B., Nyvold, C. G.
, Hansen, L. L. & Wojdacz, T. K. (2022).
IGHV-associated methylation signatures more accurately predict clinical outcomes of chronic lymphocytic leukemia patients than IGHV mutation load.
Haematologica,
107(4), 877-886.
https://doi.org/10.3324/haematol.2021.278477
Honoré, B., Andersen, M. D., Wilken, D.
, Kamper, P., d'Amore, F., Hamilton-Dutoit, S. & Ludvigsen, M. (2022).
Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling.
Cancers,
14(1), Article 247.
https://doi.org/10.3390/cancers14010247
Holst, J. M., Ludvigsen, M., Hamilton Dutoit, S. J., Bendix, K., Plesner, T. L., Nørgaard, P., Møller, M. B.
, Steiniche, T., Rabinovich, G. A.
, d'Amore, F. A. & Pedersen, M. B. (2017).
High Intratumoral Galectin-1 Is Associated with Adverse Outcome in ALK-Negative, CD30-Positive Peripheral T-Cell Lymphomas.
Blood,
130(Suppl 1), 4079-4079.
Holst, J. M., Plesner, T. L.
, Pedersen, M. B., Ludvigsen, M., Frederiksen, H., Møller, M. B., Wang, R., Tam, W., Inghirami, G.
& d'Amore, F. A. (2017).
Lympho- and Myeloproliferative Malignancies Occurring in the Same Host: Description of a Nationwide Discovery Cohort.
Blood,
130(Suppl 1), 1525-1525.
Holst, J. M., Plesner, T. L.
, Pedersen, M. B., Frederiksen, H., Møller, M. B., Clausen, M. R.
, Hansen, M. C., Hamilton-Dutoit, S. J., Nørgaard, P., Johansen, P., Eberlein, T. R., Mortensen, B. K., Mathiasen, G., Øvlisen, A., Wang, R., Wang, C., Zhang, W.
, Ommen, H. B., Stentoft, J. ... d'Amore, F. (2020).
Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort.
Haematologica,
105(10), 2432-2439.
https://doi.org/10.3324/haematol.2019.225839
Holst, J. M., Ludvigsen, M., Hamilton-Dutoit, S. J., Bendix, K., Plesner, T. L., Nørgaard, P., Møller, M. B.
, Steiniche, T., Rabinovich, G. A.
, d'Amore, F. & Pedersen, M. B. (2020).
High intratumoural galectin-1 expression predicts adverse outcome in ALK- ALCL and CD30+ PTCL-NOS.
Hematological Oncology,
38(1), 59-66.
https://doi.org/10.1002/hon.2702
Holst, J. M., Enemark, M. B., Pedersen, M. B., Lauridsen, K. L., Hybel, T. E., Clausen, M. R.
, Frederiksen, H., Møller, M. B., Nørgaard, P., Plesner, T. L.
, Hamilton-Dutoit, S. J., D’amore, F., Honoré, B. & Ludvigsen, M. (2021).
Proteomic profiling differentiates lymphoma patients with and without concurrent myeloproliferative neoplasia.
Cancers,
13(21), Article 5526.
https://doi.org/10.3390/cancers13215526
Holst, J. M., Enemark, M. B., Plesner, T. L.
, Pedersen, M. B., Ludvigsen, M. & d'Amore, F. (2021).
Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation.
Case Reports in Hematology,
2021, Article 6623706.
https://doi.org/10.1155/2021/6623706
Hollander, P.
, Kamper, P., Smedby, K., Enblad, G.
, Ludvigsen, M., Mortensen, J., Amini, RM.
, Hamilton Dutoit, S. J., d'Amore, F. A., Molin, D. & Glimelius, I. (2017).
High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome.
Blood Advances,
1(18), 1427-1439.
https://doi.org/10.1182/bloodadvances.2017006346
Hohloch, K., Lorsbach, M., Windemuth-Kieselbach, C., Gomez-Codina, J., Likesch, W., Jurczak, W., Cacchione, R., Suh, C., Johnsen, AR.
, D'Amore, F. A., Decaudin, D., Zinzani, PL. & Trümper, L. (2011).
Radioimmunotherapy confers long-term survival to lymphoma patients with acceptable toxicity: Registry analysis of 1100 patients by the international Radioimmunotherapy network (RIT-N).
Journal of Nuclear Medicine,
52(9), 1354-1360.
Herek, T. A., Bouska, A., Lone, W., Sharma, S., Amador, C., Heavican, T. B., Li, Y., Wei, Q., Jochum, D., Greiner, T. C., Smith, L., Pileri, S., Feldman, A. L., Rosenwald, A., Ott, G., Lim, S. T., Ong, C. K., Song, J., Jaffe, E. S. ... Iqbal, J. (2022).
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS.
Blood,
140(11), 1278-1290.
https://doi.org/10.1182/blood.2021015019
Heavican, T. B., Bouska, A., Yu, J., Lone, W. G., Amador, C., Gong, Q., Zhang, W., Li, Y., Dave, B. J., Nairismägi, M.-L., Greiner, T. C., Vose, J., Weisenburger, D. D., Lachel, C., Wang, C., Fu, K., Stevens, J., Lim, S. T., Ong, C. K. ... Iqbal, J. (2019).
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.
Blood,
133(15), 1664-1676.
https://doi.org/10.1182/blood-2018-09-872549
Hansen, G. A. W.
, Ludvigsen, M., Jacobsen, C., Cangemi, C., Rasmussen, L. M., Vorum, H.
& Honoré, B. (2015).
Fibulin-1C, C1 esterase inhibitor and glucose regulated protein 75 interact with the CREC proteins, calumenin and reticulocalbin.
P L o S One,
10, Article e0132283.
Hansen, J. J.
, Beier Ommen, H., Gormsen, L. C., d'Amore, F. A. & Hjørnet Kamper, P. M. (2018).
Classical Hodgkin Lymphoma Presenting with Severe, Recurrent Hypothermic Episodes.
Case Reports in Hematology,
2018, Article 3726593.
https://doi.org/10.1155/2018/3726593
Grant, C., Dunleavy, K., Janik, J. E., Shovlin, M., Steinberg, S. M.
, D'Amore, F. A., Pittaluga, S., Jaffe, E. & Wilson, W. H. (2012).
Alemtuzumab (ALZ) in combination with Dose-Adjusted EPOC (DA-EPOCH) has higher efficacy in nodal than in extranodal or leukemic peripheral T-cell lymphoma.
International Journal of Clinical Oncology.
Grant, C., Dunleavy, K., Janik, J. E., Shovlin, M., Steinberg, S. M.
, D'Amore, F. A., Maryalice, S. S., Pittaluga, S., Jaffe, E. S. & Wilson, W. H. (2012).
Efficacy of alemtuzumab (ALZ) in combination with dose-ajusted EPOCH (DA-EPOCH) in untreated nodal peripheral T-cell lymphoma.
Journal of Clinical Oncology,
30(15).
Gormsen, L. C., Wassberg, C., Molin, D., Kamper, P. M. H., Enblad, G.
& D'Amore, F. A. (2014).
Diffusely increased bone marrow 18F-FDG uptake is an independent predictor of focal bone lesions in patients with newly diagnosed classical Hodgkin Lymphoma.
Blood,
124(21).
Gisselbrecht, C., Borchmann, P.
, D'Amore, F., Illidge, T. M. & Zinzani, P. L. (2014).
Challenging CD30-positive lymphomas--current challenges, new insights and future directions: joining a conversation on CD30+ lymphomas.
Leukemia Research,
38(9), 1003.
https://doi.org/10.1016/j.leukres.2014.08.013
Ghielmini, M., Vitolo, U., Kimby, E., Montoto, S., Walewski, J., Pfreundschuh, M., Federico, M., Hoskin, P., McNamara, C. M., Caligaris-Cappio, F., Stilgenbauer, S., Marcus, R., Trneny, M., Dreger, P., Montserrat, E., Dreyling, M., Agostinelli, C., Arcaini, L., Campo, E. ... Zucca, E. (2013).
Esmo Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL) follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL).
Annals of Oncology,
24(3), 561-76.
Gang, AO., Stroem, C., Pedersen, M.
, D'Amore, F. A., Pedersen, LM., Bukh, A., Pedersen, BB., Moeller, MB., Mortensen, L. S., Gadeberg, O., Ingeberg, S., Mourits-Andersen, T., Pulczynski, S. & Brown, P. D. N. (2012).
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group. Annals of Oncology,
23(1), 147-153.
https://doi.org/10.1093/annonc/mdr058
Gang, AO., Pedersen, M.
, D'Amore, F. A., Møller-Pedersen, L., Pedersen, BA., Jensen, P., Pedersen, BB., Møller, MB., Gadeberg, O. V., Ingeberg, S., Mourits-Andersen, T., Pulczynski, S., Klausen, TW. & Brown, P. D. N. (2012).
A new simplified prognostic index with age cut-off of 70 years for patients with diffuse large B-cell lymphoma. A population-based analysis from the Danish Lymphoma Registry, LYFO.
Blood,
120(21).
Gang, AO., Pedersen, M.
, D'Amore, F. A., Pedersen, LM., Bukh, A., Pedersen, BB., Moeller, MB., Mourits-Andersen, T., Pulczynski, S. & Brown, P. D. N. (2013).
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. An updated analysis with 5 years median follow-up of the population-based investigation from the Danish Lymphoma Group.
Hematological Oncology (Online),
31(suppl 1), 167-168.
https://doi.org/10.1002/hon.2058
Gang, A. O., Pedersen, M.
, d'Amore, F., Pedersen, L. M., Jensen, B. A., Jensen, P., Møller, M. B., Mourits-Andersen, H. T., Pedersen, R. S., Klausen, T. W. & de N Brown, P. (2015).
A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry.
Leukemia and Lymphoma,
56(9), 2556-2562.
https://doi.org/10.3109/10428194.2015.1010078
Enemark, M. B., Hybel, T. E., Madsen, C.
, Lauridsen, K. L., Honoré, B., Plesner, T. L.
, Hamilton-Dutoit, S., D’amore, F. & Ludvigsen, M. (2022).
Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients.
Cancers,
14(5), Article 1316.
https://doi.org/10.3390/cancers14051316
Enemark, M. B. H., Sørensen, E. F., Hybel, T. E., Andersen, M. D., Madsen, C.
, Lauridsen, K. L., Honoré, B., d'Amore, F., Plesner, T. L.
, Hamilton-Dutoit, S. J. & Ludvigsen, M. (2023).
IDO1 Protein Is Expressed in Diagnostic Biopsies from Both Follicular and Transformed Follicular Patients.
International Journal of Molecular Sciences ,
24(8), Article 7314.
https://doi.org/10.3390/ijms24087314
El-Galaly, T. C.
, D'Amore, F. A., Brown, P. D. N.
, Christiansen, I., Spect, L., Loft, A., Bukh, A., Johnsen, HE., Madsen, C. & Hutchings, M. (2011).
Routine bone marrow biopsy adds little diagnostic information in patients with newly diagnosed Hodgkin lymphoma undergoing PET/CT staging. Blood,
118, 2627.
El-Galaly, T. C. E.
, D'Amore, F. A., Brown, P. D. N.
, Christiansen, I., Specht, L., Loft, A., Bukh, A., Johnsen, H. E., Madsen, C. & Hutchings, M. (2011).
Routine Bone Marrow Biopsy Adds Little Diagnostic Information in Patients with Newly Diagnosed Hodgkin Lymphoma Undergoing PET/CT Staging. Poster session presented at ASH, San Diego, United States.
El-Galaly, T. C.
, d'Amore, F., Mylam, K. J., de Nully Brown, P.
, Bøgsted, M., Bukh, A., Specht, L., Loft, A., Iyer, V., Hjorthaug, K., Nielsen, A. L.
, Christiansen, I., Madsen, C., Johnsen, H. E. & Hutchings, M. (2012).
Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography-Staged Treatment-Naive Patients With Hodgkin Lymphoma.
Journal of Clinical Oncology,
30(36), 4508-4514.
https://doi.org/10.1200/JCO.2012.42.4036
El-Galaly, T. C., Hutchings, M., Juul Mylam, K., Brown, P. D. N., Bukh, A.
, Kamper, P., Johnsen, H. E.
& D'Amore, F. A. (2012).
Clinical Features and Outcome in Newly Diagnosed Hodgkin Lymphoma Patients Presenting with PET/CT-Ascertained Focal Skeletal Lesions.
El-Galaly, T. C., Juul Mylam, K., Brown, P. D. N., Bukh, A., Johnsen, H. E., Madsen, C.
, D'Amore, F. A. & Hutchings, M. (2012).
Disease Extent in Newly Diagnosed Hodgkin Lymphoma: A Comparison of CT and PET/CT Staged Patients.
El-Galaly, T. C., Mylam, K., Brown, P., Rossing, M., Gang, A., Haglund, A., Arboe, B., Clausen, M., Jensen, P., Pedersen, M., Bukh, A., Amdi Jensen, B., Poulsen, C.
, D'Amore, F. A. & Hutchings, M. (2013).
Patient-reported symptoms are still the single most important factor for detecting lymphoma relapse.
Hematological Oncology,
31.
El-Galaly, T. C., Hutchings, M., Mylam, K. J., de Nully Brown, P., Bukh, A., Johnsen, H. E.
, Kamper, P., Loft, A., Iyer, V.
, Gormsen, L. C., Nielsen, A. L.
, Bøgsted, M. & d'Amore, F. (2013).
Impact of 18F-FDG PET/CT Staging in Newly Diagnosed Classical Hodgkin Lymphoma: Less Cases with Stage I Disease and More with Skeletal Involvement.
Leukemia and Lymphoma.
https://doi.org/10.3109/10428194.2013.875169
El-Galaly, T. C., Mylam, K. J.
, Bøgsted, M., Brown, P. D. N., Rossing, M., Gang, A. O., Haglund, A., Arboe, B., Clausen, M. R., Jensen, P.
, Pedersen, M., Bukh, A., Jensen, B. A., Poulsen, C. B.
, d'Amore, F. & Hutchings, M. (2014).
Role of routine imaging in detecting recurrent lymphoma; a review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.
American Journal of Hematology,
89(6), 575-580.
https://doi.org/10.1002/ajh.23688
Dybkær, K., Iqbal, J., Zhou, G., Geng, H., Xiao, L.
, Schmitz, A., d'Amore, F. A. & Chan, W. C. (2007).
Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: Gene expression signatures indicative of novel molecular signaling pathways. BMC Gemomics.
BMC Gemomics,
8(230).
de Leval, L., Alizadeh, A. A., Bergsagel, P. L., Campo, E., Davies, A., Dogan, A., Fitzgibbon, J., Horwitz, S. M., Melnick, A. M., Morice, W. G., Morin, R. D., Nadel, B., Pileri, S. A., Rosenquist, R., Rossi, D., Salaverria, I., Steidl, C., Treon, S. P., Zelenetz, A. D. ... Scott, D. W. (2022).
Genomic profiling for clinical decision making in lymphoid neoplasms.
Blood,
140(21), 2193-2227.
https://doi.org/10.1182/blood.2022015854
de Chadarevian, JP., Wolk, JH., Inniss, S., Lischner, HW.
, d'Amore, F. A., Faerber, EN. & Isaacson, GC. (1997).
A newly recognized cause of wheezing:AIDS-related bronchial leiomyomas. Pediatric Pulmonology,
24((2)), 106-10.
D'Amore, F. A., Madsen, J., Nielsen, R., Engebjerg, M., Sørensen, H. & Bukh, A. (2010).
Use of statins and prognosis in patients with CD-20-positive "De novo" diffuse large b cell lymphoma (DLBCL) treated with rituximab containing regimens.
Haematologica, 282.
D'Amore, F. A., Jurczak, W., Skotnicki, A. B., Deptala, A., Windemuth-Kieselbach, C., Lorsbach, M., Delaloye, A. B., Cheolwon, S., Zinzani, P. L., Cacchione, R., Linkesch, W. & Truemper, L. H. (2009).
Consolidation with radioimmunotherapy may prolong survival in first remission of mantle cell lymphoma patients uneligible for stem cell transplantation, an analysis of the international RIT-network.
Blood,
114(22), 22.
D'Amore, F. A., Relander, T., Lauritzsen, GF., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Østerborg, A., Merup, M., Brown, P. D. N., Østenstad, B., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Sundström, C., Delabie, J., Ralfkiaer, E., Vornanen, M. & Toldbod, H. (2012).
High-dose chemotherapy and autologous stem cell transplantation in previously untreated peripheral T-cell lymphoma - final analysis of a large prospective multicenter study (NLG-T-01).
Blood,
118, 331.
D'Amore, F. A., Gomes da Silva, M., Leppa, S., Relander, T., Pezzutto, A., Lauritzsen, GF., Weidmann, E., Van Gelder, M., Merup, M., Hagberg, H., Fagerli, UM., Brown, P. D. N., Boye Hansen, P., Mariz, JM., Jankovska, M., Walewski, J., Doorduijn, J., van Hoof, A.
, Christiansen, I. ... Toldbod, H. (2011).
First interim safety analysis of a phase III randomized trial in a newly diagnosed systemic peripheral T-cell lymphoma trated with CHOP chemotherapy with or without alemtuzumab and consolidated by autologous hematopoietic stem cell transplant. Blood,
118, 4110.
D'Amore, F. A., Leppä, S., Gomes da Silva, M., Relander, T., Brown, P. D. N., Weidmann, E., Lauritzsen, GF., Pezzutto, A., Van Hoof, A., Van Gelder, M., Doorduijn, J., Wu, KL., Kluin-Nelemans, JC., Lugtenburg, PJ., Jankovska, M., Merup, M., Fagerli, U.-M., Walewski, J., Hagberg, H. ... Toldbod, H. (2012).
First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma PatientsTreated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy.
Blood,
120(57).
D'Amore, F. A., Relander, T., Lauritzsen, GF., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Ôsterborg, A., Merup, M., Brown, P. D. N., Kuittinen, O., Erlanson, M., Østenstad, B., Fagerli, U.-M., Gadeberg, OV., Sundström, C., Delabie, J., Ralfkiær, E. M., Vornanen, M. & Toldbod, H. (2012).
Upfront Autologuos Stem Cell Transplantation in Peripheral T-cell Lymphoma (NLG-T-01).
Journal of Clinical Oncology,
30(25), 3093-3099.
D'Amore, F. A., Lauritzsen, G. F., Relander, T., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Osterborg, A., Merup, M., Brown, P., Kuittinen, O., Erlanson, M., Ostenstad, B., Fagerli, U., Gadeberg, O., Sundstrom, C., Delabie, J., Ralfkiaer, E., Vornanen, M.
& Toldbod, H. (2013).
Late relapses in peripheral T-cell lymphoma patients treated in the nordic NLG-T-01 trial.
Hematological Oncology,
31, 176-177.